SUZANNE VOGEL-SCIBILIA: Open Payments
NPI 1063407468 · BEAVER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,437 in 22 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $1,407 · 2025 $4,437
Speaker / faculty: $3,876Food & beverage: $552Travel & lodging: $9
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 5 | $4,047 |
| Otsuka America Pharmaceutical, Inc. | 4 | $92 |
| ABBVIE INC. | 3 | $69 |
| Vanda Pharmaceuticals Inc. | 2 | $61 |
| Alkermes, Inc. | 3 | $60 |
| Janssen Pharmaceuticals, Inc | 2 | $57 |
| Lundbeck LLC | 2 | $36 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
Products named: COBENFY, REXULTI, VRAYLAR, FANAPT, ARISTADA, INVEGA SUSTENNA, ABILIFY MAINTENA, UZEDY.
Industry payments across PA — which companies pay providers there.
